From: Low serum amylase in association with metabolic syndrome and diabetes: A community-based study
 | Model 1 | Model 2 | Model 3 |
---|---|---|---|
Current amylase quartiles* | MetS | ||
   Q1 (Lowest) | 2.79 (2.04-3.82) | 3.30 (2.38-4.57) | 2.07 (1.39-3.07) |
   Q2 | 1.92 (1.38-2.66) | 2.21 (1.58-3.09) | 1.70 (1.14-2.54) |
   Q3 | 1.69 (1.22-2.35) | 1.85 (1.32-2.58) | 1.56 (1.05-2.31) |
   Q4 (Highest) reference | 1 | 1 | 1 |
   P for trend | 0.02 | 0.02 | 0.03 |
 | Diabetes | ||
   Q1 (Lowest) | 1.97 (1.32-2.93) | 2.73 (1.79-4.18) | 2.76 (1.49-5.11) |
   Q2 | 1.23 (0.79-1.89) | 1.57 (1.00-2.46) | 1.95 (1.03-3.68) |
   Q3 | 0.93 (0.59-1.47) | 1.07 (0.67-1.70) | 1.16 (0.59-2.29) |
   Q4 (Highest) reference | 1 | 1 | 1 |
   P for trend | 0.13 | 0.08 | 0.03 |
Prior amylase quartiles (n = 571) ** | MetS | ||
   Q1 (Lowest) | 4.21 (1.81-9.76) | 4.82 (2.01-11.5) | 5.88 (2.05-16.8) |
   Q2 | 3.37 (1.47-7.72) | 3.78 (1.61-8.85) | 3.97 (1.45-10.8) |
   Q3 | 1.22 (0.47-3.19) | 1.34 (0.51-3.53) | 1.68 (0.54-5.19) |
   Q4 (Highest) reference | 1 | 1 | 1 |
   P for trend | 0.04 | 0.04 | 0.02 |
 | Diabetes | ||
   Q1 (Lowest) | 3.70 (0.73-18.7) | 3.74 (0.68-20.6) | 3.26 (0.45-23.4) |
   Q2 | 0.92 (0.13-6.59) | 0.91 (0.12-6.89) | 0.60 (0.06-5.56) |
   Q3 | 1.46 (0.24-8.86) | 1.65 (0.26-10.5) | 1.78 (0.23-14.1) |
   Q4 (Highest) reference | 1 | 1 | 1 |
   P for trend | 0.25 | 0.27 | 0.38 |